Skip to Content

'
Christopher E. Pelloski, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2001 Northwestern University Medical School, Chicago, IL, MD, Medicine
1996 Albion College, Albion, MI, BA, Chemistry

Postgraduate Training

7/2002-6/2006 Clinical Residency, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Dr. Thomas Buchholz
6/2001-6/2002 Clinical Internship, The University of Texas - Houston Medical School, Houston, TX, Dr. Mark Farnie

Board Certifications

6/2008 American Board of Radiology

Selected Publications

Peer-Reviewed Original Research Articles
1. Rivera AL, Pelloski CE, Gilbert MR, Colman H, De La Cruz C, Sulman EP, Bekele NB, and Aldape KD. MGMT promoter methylation is associated increased time to progression and overall survival time in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-Oncology. In Press.
2. Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MV, Sawaya RE, Lang FF, Rao G. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg, 3/20/2009. e-Pub 3/20/2009. PMID: 19301968.
3. McDonald JM, Pelloski CE, Ledoux A, Sun M, Raso G, Komaki R, Ignacio Wistuba II, Bekele BN, Aldape KD. Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung. Clinical Cancer Research 14(23):7832-7, 12/1/2008. PMCID: PMC2614348.
4. Bhat KP, Pelloski CE, Zhang Y, Kim SH, Delacruz C, Rehli M, Aldape KD. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett 582(21-22):3193-200, 8/14/2008. e-Pub 8/15/2008. PMID: 18708058.
5. Mahajan A, Woo SY, Kornguth DG, Hughes D, Huh W, Chang EL, Herzog CE, Pelloski CE, Anderson P. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer 50(5):976-82, 5/2008. PMID: 18213710.
6. Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG, Buckner JC, James CD, Aldape K. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol 25(16):2288-94, 6/1/2007. PMID: 17538175.
7. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res 12(13):3935-41, 7/1/2006. PMID: 16818690.
8. Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 30(5):657-64, 5/2006. PMID: 16699322.
9. Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, Sawaya R, Huang S. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66(7):3593-602, 4/1/2006. PMID: 16585184.
10. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 63(2):615-21, 10/1/2005. PMID: 16168853.
11. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 5/1/2005. PMID: 15850913.
12. Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H, Yang H, Ledoux A, Blair H, Passe S, Jenkins RB, Aldape KD. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res 11(9):3326-34, 5/1/2005. PMID: 15867231.
13. Pelloski CE, Wilder RB, Ha CS, Hess MA, Cabanillas FF, Cox JD. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol 59(2):145-51, 5/2001. PMID: 11325442.
14. Venta LA, Kim JP, Pelloski CE, Morrow M. Management of complex breast cysts. AJR Am J Roentgenol 173(5):1331-6, 11/1999. PMID: 10541113.

Invited Articles
1. Rivera AL, Pelloski CE, Sulman E, Aldape K. Prognostic and predictive markers in glioma and other neuroepithelial tumors. Curr Probl Cancer 32(3):97-123, May-Jun, 5/2008. PMID: 18501774.

Last updated: 9/2/2009